ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison

Int J Cardiol. 2016 Jul 1:214:483-4. doi: 10.1016/j.ijcard.2016.04.016. Epub 2016 Apr 7.

¹ Cardiovascular Clinic Institute, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.
² Deutsches Zentrum für Herz und Kreislauf Forschung, Standort Rhein-Main, Mainz, Germany.
³ Cardiac Department, National University Heart Centre Singapore, National University Health System, Singapore.
⁴ Cardiocenter, Third Faculty of Medicine, Charles University in Prague, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
⁵ Cardiology Department, Interventional Cardiology Unit, Virgen de la Arrixaca Hospital, Murcia, Spain.
⁶ Institute of Cardiology, Hospital of Bellvitge, Barcelona, Spain.
⁷ Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.

No abstract available

Keywords: BVS; Everolimus-eluting stent; STEMI.

Publication types